Orum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief ...
Because ARM licenses its designs, multiple companies can integrate ARM technology into a single system-on-a-chip, or SoC. A ...